
Latest
AngioDynamics Earnings Put Med Tech Growth in Focus
AngioDynamics posted 6.9% sales growth and stronger Med Tech momentum while reiterating fiscal 2027 guidance ahead of a CEO transition.

AngioDynamics posted 6.9% sales growth and stronger Med Tech momentum while reiterating fiscal 2027 guidance ahead of a CEO transition.

Delta reports September-quarter results today, with investors focused on mid-teens revenue growth, margins, fuel costs and full-year guidance.